Hims & Hers Health

What a week overall.. $Merck(MRK.US), $Cheesecake Factory(CAKE.US), $Hims & Hers Health(HIMS.US), $GLD, $SLV, $Freeport Mcmoran(FCX.US), to name a few.. I have $Merck(MRK.US), but missed $Moderna(MRNA.US).

Have a happy $Hims & Hers Health(HIMS.US) weekend if you know what I mean.. I am talking about the trade and chart😂

$Hims & Hers Health(HIMS.US) | Barclays 𝗺𝗮𝗶𝗻𝘁𝗮𝗶𝗻𝘀 𝗢𝘃𝗲𝗿𝘄𝗲𝗶𝗴𝗵𝘁 on 𝗛𝗶𝗺𝘀 & 𝗛𝗲𝗿𝘀 𝗛𝗲𝗮𝗹𝘁𝗵, cuts PT to $𝟯𝟱 from $𝟯𝟵

Analyst sees faster revenue growth but near-term margin pressure from investments supporting growth.

$Hims & Hers Health(HIMS.US) | Canaccord 𝗿𝗲𝗶𝘁𝗲𝗿𝗮𝘁𝗲𝘀 𝗕𝘂𝘆 on 𝗛𝗶𝗺𝘀 & 𝗛𝗲𝗿𝘀 𝗛𝗲𝗮𝗹𝘁𝗵, maintains PT at $𝟰𝟬

Analyst sees strong Q2 results and momentum in newer specialties, international markets, and AI supporting the reiterated Buy.

For $Hims & Hers Health(HIMS.US) earnings tonight after the bell, the cleanest near-term options estimate I’m seeing is about a ±14.4% implied earnings move for the Aug. 14 weekly expiration.

Using $31.72 spot:

Implied move: ≈ ±$4.57

Upside implied target: ≈ $36.29

Downside implied target: ≈ $27.15

The upper Bollinger Band is $36.83, basically sitting right around the bullish implied-move zone. On the downside, $27.15 lands almost directly on the 100-day MA at $27.76.

200-day MA at $29.64 would be the first major downside technical level before that.

$Hims & Hers Health(HIMS.US) Earnings Map

$39.05 — July swing high / breakout target

$36.30–$36.85 — implied upside + upper Bollinger Band

$31.72 — current price

$31.33 — 50 DMA

$31.10 — 21 EMA

$30.76 — 8 EMA

$29.64 — 200 DMA

$27.15–$27.76 — implied downside + 100 DMA

The setup is pretty clean technically: $36–37 is the expected bullish landing zone; $27–28 is the bearish landing zone.

A move through either side would represent an earnings move beyond what the options market is broadly pricing.

📢 𝗝𝗨𝗦𝗧 𝗜𝗡: $Hims & Hers Health(HIMS.US) Hims & Hers Launches AI-Powered Hers App for Women's Weight Loss Care

👉 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀:

➤ 𝗛𝗶𝗺𝘀 & 𝗛𝗲𝗿𝘀 unveils an AI-integrated 𝗛𝗲𝗿𝘀 app experience.

➤ AI, providers, and care teams collaborate within a single conversation thread.

➤ AI uses patient history, treatment plans, and progress for personalized support.

➤ Licensed providers retain authority over all prescriptions and clinical decisions.

➤ Company introduces a 𝗛𝗲𝗿𝘀 𝘀𝗺𝗮𝗿𝘁 𝘀𝗰𝗮𝗹𝗲 at no additional cost.

➤ Smart scale syncs weight and 𝗚𝗟𝗣-𝟭 progress directly to the app.

➤ Providers, care teams, and AI can access synced patient progress data.

➤ Company describes the platform as a "𝗳𝗶𝗿𝘀𝘁-𝗼𝗳-𝗶𝘁𝘀-𝗸𝗶𝗻𝗱" AI-integrated care experience.

➤ Hims & Hers plans to expand AI capabilities to the 𝗛𝗶𝗺𝘀 app and additional health categories.

👉 𝗪𝗵𝘆 𝗧𝗵𝗶𝘀 𝗠𝗮𝘁𝘁𝗲𝗿𝘀:

➤ Deepens AI integration across digital healthcare and chronic weight management.

➤ Could improve care coordination between patients, AI, and licensed providers.

➤ Strengthens Hims & Hers' competitive position in AI-enabled telehealth.

➤ Expands the company's ecosystem beyond medication into connected health devices.

👉 𝗘𝘅𝗽𝗲𝗿𝘁 𝗦𝘁𝗮𝘁𝗲𝗺𝗲𝗻𝘁𝘀:

𝗠𝗼 𝗘𝗹𝘀𝗵𝗲𝗻𝗮𝘄𝘆, Chief Technology Officer at Hims & Hers:

"This new experience on the Hers app embeds intelligence at every step of the care experience. It knows each woman's treatment plan, delivers support unique to her, and brings a provider into the conversation when clinical judgment is needed."

𝗝𝗲𝘀𝘀𝗶𝗰𝗮 𝗦𝗵𝗲𝗽𝗵𝗲𝗿𝗱, 𝗠𝗗, 𝗙𝗔𝗖𝗢𝗚, Chief Medical Officer:

"the clinical oversight, lifestyle guidance, and support a woman receives between appointments can matter just as much as the treatment itself."